| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Guy A Cabral, Thomas J Rogers, Aron H Lichtma. Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 2. 2016-04-01. PMID:26054900. |
the potential untoward effects as well as beneficial uses of marijuana, its phytocannabinoid composition, and synthesized cannabinoid analogs are discussed. |
2016-04-01 |
2023-08-13 |
human |
| Sagnik Bhattacharyya, Irina Falkenberg, Rocio Martin-Santos, Zerrin Atakan, Jose A Crippa, Vincent Giampietro, Mick Brammer, Philip McGuir. Cannabinoid modulation of functional connectivity within regions processing attentional salience. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 40. issue 6. 2016-03-29. PMID:25249057. |
although these areas show differential activation under the influence of delta-9-tetrahydrocannabinol (delta-9-thc) and cannabidiol (cbd), the two major derivatives of cannabis sativa, little is known about the effects of these cannabinoids on the functional connectivity between these regions. |
2016-03-29 |
2023-08-13 |
Not clear |
| A Ossato, A Vigolo, C Trapella, C Seri, C Rimondo, G Serpelloni, M Mart. JWH-018 impairs sensorimotor functions in mice. Neuroscience. vol 300. 2016-03-29. PMID:25987201. |
naphthalen-1-yl-(1-pentylindol-3-yl)methanone (jwh-018) is a synthetic cannabinoid agonist illegally marketed in "spice" and "herbal blend" for its psychoactive effect greater than those produced by cannabis. |
2016-03-29 |
2023-08-13 |
mouse |
| Michael B Gatch, Michael J Forste. Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market. Behavioural pharmacology. vol 26. issue 5. 2016-03-29. PMID:26061356. |
when synthetic cannabinoid compounds became controlled by state and federal governments, different, noncontrolled compounds began to appear as marijuana substitutes. |
2016-03-29 |
2023-08-13 |
mouse |
| Marco Colizzi, Leonardo Fazio, Laura Ferranti, Annamaria Porcelli, Rita Masellis, Daniela Marvulli, Aurora Bonvino, Gianluca Ursini, Giuseppe Blasi, Alessandro Bertolin. Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 40. issue 3. 2016-03-15. PMID:25139064. |
the logical interaction between genetically determined cannabinoid signaling and cannabis use has not been determined. |
2016-03-15 |
2023-08-13 |
human |
| Christian Giroud, Mariangela de Cesare, Aurélie Berthet, Vincent Varlet, Nicolas Concha-Lozano, Bernard Favra. E-Cigarettes: A Review of New Trends in Cannabis Use. International journal of environmental research and public health. vol 12. issue 8. 2016-03-15. PMID:26308021. |
the emergence of electronic cigarettes (e-cigs) has given cannabis smokers a new method of inhaling cannabinoids. |
2016-03-15 |
2023-08-13 |
Not clear |
| Christian Giroud, Mariangela de Cesare, Aurélie Berthet, Vincent Varlet, Nicolas Concha-Lozano, Bernard Favra. E-Cigarettes: A Review of New Trends in Cannabis Use. International journal of environmental research and public health. vol 12. issue 8. 2016-03-15. PMID:26308021. |
first, it is assumed that vaporizing cannabinoids at lower temperatures is safer because it produces smaller amounts of toxic substances than the hot combustion of a marijuana cigarette. |
2016-03-15 |
2023-08-13 |
Not clear |
| Eliani Spinelli, Allan J Barnes, Sheena Young, Marisol S Castaneto, Thomas M Martin, Kevin L Klette, Marilyn A Huesti. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids. Drug testing and analysis. vol 7. issue 6. 2016-03-14. PMID:25167963. |
synthetic cannabinoids are marketed as legal alternatives to cannabis, as routine urine cannabinoid immunoassays do not detect synthetic cannabinoids. |
2016-03-14 |
2023-08-13 |
Not clear |
| Dayong Lee, Ryan Vandrey, Damodara R Mendu, Jeannie A Murray, Allan J Barnes, Marilyn A Huesti. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Drug testing and analysis. vol 7. issue 6. 2016-03-14. PMID:25220020. |
oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. |
2016-03-14 |
2023-08-13 |
Not clear |
| Dayong Lee, Ryan Vandrey, Damodara R Mendu, Jeannie A Murray, Allan J Barnes, Marilyn A Huesti. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Drug testing and analysis. vol 7. issue 6. 2016-03-14. PMID:25220020. |
given that chronic cannabis smokers often engage in drug administration multiple times daily, evaluating of cannabinoid pharmacokinetics during ad libitum smoking is important for practical development of analytical methods and informed interpretation of test results. |
2016-03-14 |
2023-08-13 |
Not clear |
| Dayong Lee, Ryan Vandrey, Damodara R Mendu, Jeannie A Murray, Allan J Barnes, Marilyn A Huesti. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Drug testing and analysis. vol 7. issue 6. 2016-03-14. PMID:25220020. |
cannabinoid disposition in of was highly influenced by Δtime and composition of smoked cannabis. |
2016-03-14 |
2023-08-13 |
Not clear |
| Dayong Lee, Ryan Vandrey, Damodara R Mendu, Jeannie A Murray, Allan J Barnes, Marilyn A Huesti. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Drug testing and analysis. vol 7. issue 6. 2016-03-14. PMID:25220020. |
furthermore, cannabinoid of concentrations increased over ad libitum smoking days, in parallel with increased cannabis self-administration, possibly reflecting development of increased cannabis tolerance. |
2016-03-14 |
2023-08-13 |
Not clear |
| Eric P Baro. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …. Headache. vol 55. issue 6. 2016-03-14. PMID:26015168. |
comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it's been …. |
2016-03-14 |
2023-08-13 |
Not clear |
| Eric P Baro. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …. Headache. vol 55. issue 6. 2016-03-14. PMID:26015168. |
almost half of the united states has now legalized medicinal cannabis, several states have legalized recreational use, and others have legalized cannabidiol-only use, which is one of many therapeutic cannabinoids extracted from cannabis. |
2016-03-14 |
2023-08-13 |
Not clear |
| Scott E Hadland, John R Knight, Sion K Harri. Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice. Journal of developmental and behavioral pediatrics : JDBP. vol 36. issue 2. 2016-03-11. PMID:25650954. |
it then outlines the increasingly well-recognized neurocognitive changes shown to occur in adolescents who use cannabis regularly, highlighting the unique susceptibility of the developing adolescent brain and describing the role of the endocannabinoid system in normal neurodevelopment. |
2016-03-11 |
2023-08-13 |
Not clear |
| Ewa Kozela, Ana Juknat, Nathali Kaushansky, Avraham Ben-Nun, Giovanni Coppola, Zvi Voge. Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells. Journal of neuroinflammation. vol 12. 2016-03-07. PMID:25880134. |
cannabidiol, a non-psychoactive cannabinoid, leads to egr2-dependent anergy in activated encephalitogenic t cells. |
2016-03-07 |
2023-08-13 |
mouse |
| Ewa Kozela, Ana Juknat, Nathali Kaushansky, Avraham Ben-Nun, Giovanni Coppola, Zvi Voge. Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells. Journal of neuroinflammation. vol 12. 2016-03-07. PMID:25880134. |
cannabidiol (cbd), the main non-psychoactive cannabinoid, has been previously shown by us to ameliorate clinical symptoms and to decrease inflammation in myelin oligodendrocyte glycoprotein (mog)35-55-induced mouse experimental autoimmune encephalomyelitis model of multiple sclerosis as well as to decrease mog35-55-induced t cell proliferation and il-17 secretion. |
2016-03-07 |
2023-08-13 |
mouse |
| Matthew W Giese, Mark A Lewis, Laura Giese, Kevin M Smit. Development and Validation of a Reliable and Robust Method for the Analysis of Cannabinoids and Terpenes in Cannabis. Journal of AOAC International. vol 98. issue 6. 2016-03-07. PMID:26651562. |
development and validation of a reliable and robust method for the analysis of cannabinoids and terpenes in cannabis. |
2016-03-07 |
2023-08-13 |
Not clear |
| Waseem Gul, Shahbaz W Gul, Mohamed M Radwan, Amira S Wanas, Zlatko Mehmedic, Ikhlas I Khan, Maged H M Sharaf, Mahmoud A ElSohl. Determination of 11 Cannabinoids in Biomass and Extracts of Different Varieties of Cannabis Using High-Performance Liquid Chromatography. Journal of AOAC International. vol 98. issue 6. 2016-03-07. PMID:26651563. |
determination of 11 cannabinoids in biomass and extracts of different varieties of cannabis using high-performance liquid chromatography. |
2016-03-07 |
2023-08-13 |
Not clear |
| Waseem Gul, Shahbaz W Gul, Mohamed M Radwan, Amira S Wanas, Zlatko Mehmedic, Ikhlas I Khan, Maged H M Sharaf, Mahmoud A ElSohl. Determination of 11 Cannabinoids in Biomass and Extracts of Different Varieties of Cannabis Using High-Performance Liquid Chromatography. Journal of AOAC International. vol 98. issue 6. 2016-03-07. PMID:26651563. |
an hplc single-laboratory validation was performed for the detection and quantification of the 11 major cannabinoids in most cannabis varieties, namely, cannabidiolic acid (cbda), cannabigerolic acid (cbga), cannabigerol (cbg), cannabidiol (cbd), tetrahydrocannabivarin (thcv), cannabinol (cbn), Δ9-trans-tetrahydrocannabinol (Δ9-thc), Δ8-trans-tetrahydrocannabinol (Δ8-thc), cannabicyclol (cbl), cannabichromene (cbc), and Δ9-tetrahydrocannabinolic acid-a (thcaa). |
2016-03-07 |
2023-08-13 |
Not clear |